Tau Therapeutics' Seed VC Round

Tau Therapeutics raised a round of funding on February 06, 2006. Investors include CIT GAP Funds.

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, …

Articles about Tau Therapeutics' Seed VC Round: